Effects of Attractive Pickering emulsion gels loaded with oxaliplatin and lactate dehydrogenase inhibitors in hepatocellular carcinoma.
Pickering emulsion
DOI:
10.1200/jco.2024.42.16_suppl.e16235
Publication Date:
2024-07-03T19:28:03Z
AUTHORS (5)
ABSTRACT
e16235 Background: Oxaliplatin (OXA) can be used as a palliative treatment for advanced hepatocellular carcinoma (HCC). While most patients still have rapid disease progression after OXA due to the drug resistance. The lactate dehydrogenase A (LDHA) inhibitors reduce inflammation-induced effects, metastasis, and proliferation potential of cancer cells. combination LDHA inhibitor may an effective HCC. Methods: We adopt water-in-oil attractive Pickering emulsion gel (APEG) deliver inhibitor, GSK2837808A (GSK). is dissolved in water GSK iodized oil. injected OXA+GSK@gel into peritumoral tissues subcutaneously tumorigenic HCC model mice, then observe tumor size. Next, we apply immunohistochemical staining terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay on dissected tumors explore cell apoptosis. Meanwhile, flow analysis applied investigate immune microenvironment Results: This drugs-loaded APEG has good biocompatibility release slowly. significant anti-tumor effect model, which effectively inhibit promote confirm that it could activate infiltration CD8 + T cells was increased, thereby providing better effect. Conclusions: results suggest APEGs loaded with improve delivery efficiency enhance therapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....